Dr. Debra L. Richardson
Claim this profileUniversity of Oklahoma Health Sciences Center
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
33 reported clinical trials
52 drugs studied
About Debra L. Richardson
Education:
- Undergraduate degree from the University of Virginia, Charlottesville, VA.
- Attended Medical School at New York Medical College, Valhalla, NY.
- Completed Residency at the University of Connecticut School of Medicine, Farmington, CT.
- Fellowship at The Ohio State University College of Medicine, Columbus, OH.
Experience:
- Board Certified in Obstetrics and Gynecology, and Gynecologic Oncology.
- Associate Professor and Chief, Section of Gynecologic Oncology, at the Stephenson Cancer Center, University of Oklahoma Health Sciences Center.
- Specializes in the treatment of gynecologic cancers, fertility-sparing management, and phase I clinical trials.
- Over 20 years of experience in the medical field.
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
FRα positive
2Fallopian Tube Cancer
Stage IV
Stage III
FRα positive
Affiliated Hospitals
Clinical Trials Debra L. Richardson is currently running
Olvi-Vec + Chemotherapy
for Ovarian Cancer
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting2 awards Phase 37 criteria
ARTS-021
for Advanced Cancer
This study, the first clinical trial of AVZO-021, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and anti-tumor effects of AVZO-021 in patients with advanced solid tumors. AVZO-021 is an oral medication that inhibits cyclin-dependent kinase 2 (CDK 2).
Recruiting1 award Phase 1 & 2
More about Debra L. Richardson
Clinical Trial Related3 years of experience running clinical trials · Led 33 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Debra L. Richardson has experience with
- Niraparib
- Pembrolizumab
- Carboplatin
- Gemcitabine
- Dostarlimab
- Bevacizumab
Breakdown of trials Debra L. Richardson has run
Ovarian Cancer
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Debra L. Richardson specialize in?
Debra L. Richardson focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Debra L. Richardson currently recruiting for clinical trials?
Yes, Debra L. Richardson is currently recruiting for 14 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Debra L. Richardson has studied deeply?
Yes, Debra L. Richardson has studied treatments such as Niraparib, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with Debra L. Richardson?
Apply for one of the trials that Debra L. Richardson is conducting.
What is the office address of Debra L. Richardson?
The office of Debra L. Richardson is located at: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the University of Oklahoma Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.